CHPA Benzocaine Toothache Relief Efficacy Study Protocol Submitted To FDA
This article was originally published in The Tan Sheet
Executive Summary
Individuals with either moderate or severe toothache pain are included in a study protocol on the effectiveness of benzocaine for toothache relief submitted to FDA by the Consumer Healthcare Products Association Oral Discomfort Task Group.
You may also be interested in...
Eugenol Inclusion In Oral Pain Monograph Requires Actual Use Data – FDA
Both a clinical safety trial and an actual use study are necessary to support including eugenol in the oral discomfort (relief) products final monograph, FDA tells the Consumer Healthcare Products Association
Eugenol Inclusion In Oral Pain Monograph Requires Actual Use Data – FDA
Both a clinical safety trial and an actual use study are necessary to support including eugenol in the oral discomfort (relief) products final monograph, FDA tells the Consumer Healthcare Products Association
Eugenol Inclusion In Oral Pain Monograph Requires Actual Use Data – FDA
Both a clinical safety trial and an actual use study are necessary to support including eugenol in the oral discomfort (relief) products final monograph, FDA tells the Consumer Healthcare Products Association